ORALE KOMPLEMENT-FAKTOR-D-INHIBITOREN

Patent europeic · EP4041238 · En vigur

Inscripziun en il register

Numer da publicaziun
EP4041238
Numer da la dumonda
EP20874925
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
09-10-2020
Publitgà
17-08-2022
Concedì
03-06-2026
La protecziun finescha il pli tard
08-10-2040
Proxima taxa annuala scadenta
31-10-2026
Classas IPC
C07D 405/04 (2006.01)
A61K 31/506 (2006.01)
A61K 31/519 (2006.01)
A61K 31/5377 (2006.01)
Prioritad
US 201962912929 P 09.10.2019
Dumonda PCT
PCT/US2020/054992 09.10.2020
Publicaziun PCT
WO2021/072198 15.04.2021
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 03-06-2026

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 03.06.2026

Partidas

Inventur

KOTIAN, Pravin L.

Hoover, AL 35226, US

BABU, Yarlagadda S.

Birmingham, AL 35244, US

ZHANG, Weihe

Vestavia Hills, AL 35226, US

LU, Peng-Cheng

Vestavia Hills, AL 35243, US

SPAULDING, Andrew E.

Hoover, AL 35226, US

LV, Wei

Hoover, AL 35244, US

DANG, Zhao

Vestavia Hills, AL 35216, US

RAMAN, Krishnan

Birmingham, AL 35216, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.